Reply to Gan
et al.
, to Calzetta
et al.
, and to Poor
Am J Respir Crit Care Med
.
2024 Jan 15;209(2):226-228.
doi: 10.1164/rccm.202309-1657LE.
Authors
Antonio Anzueto
1
2
,
Igor Z Barjaktarevic
3
,
Thomas M Siler
4
,
Tara Rheault
5
,
Thomas Bengtsson
6
,
Kathleen Rickard
5
,
Frank Sciurba
7
Affiliations
1
South Texas Veterans Health Care System, San Antonio, Texas.
2
University of Texas Health, San Antonio, Texas.
3
Division of Pulmonary and Critical Care, University of California Los Angeles, Los Angeles, California.
4
Midwest Chest Consultants, PC, St. Charles, Missouri.
5
Verona Pharma Plc, London, United Kingdom and Raleigh, North Carolina.
6
StatMind AB, Lund, Sweden; and.
7
Division of Pulmonary and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
PMID:
37939377
PMCID:
PMC10806414
DOI:
10.1164/rccm.202309-1657LE
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
Grants and funding
Verona Pharma